Gene · 5376
Papers3,310
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,310
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Editorial: Diagnosis of neuromuscular disorders in the era of personalized genomic medicine. | Front Neurol | 2023 | 37292125 | PubTator, text mining | PubMed |
| ACDC: a general approach for detecting phenotype or exposure associated co-expression. | Front Med (Lausanne) | 2023 | 37275375 | PubTator, text mining | PubMed |
| Genome sequencing with comprehensive variant calling identifies structural variants and repeat expansions in a large fraction of individuals with ataxia and/or neuromuscular disorders. | Front Neurol | 2023 | 37273706 | PubTator, text mining | PubMed |
| COVID-19 as a trigger of Guillain-Barré syndrome: A review of the molecular mechanism. | Immun Inflamm Dis | 2023 | 37249286 | PubTator, text mining | PubMed |
| Lymphomatoid granulomatosis with the central nervous system involvement as the main manifestation: a case report. | BMC Neurol | 2023 | 37248444 | PubTator, text mining | PubMed |
| Prognostic Values of Gene Copy Number Alterations in Prostate Cancer. | Genes (Basel) | 2023 | 37239316 | PubTator, text mining | PubMed |
| A Novel Family with Demyelinating Charcot-Marie-Tooth Disease Caused by a Mutation in the PMP2 Gene: A Case Series of Nine Patients and a Brief Review of the Literature. | Children (Basel) | 2023 | 37238449 | PubTator, text mining | PubMed |
| Fatigue, depression, and product tolerability during long-term treatment with intravenous immunoglobulin (Gamunex® 10%) in patients with chronic inflammatory demyelinating polyneuropathy. | BMC Neurol | 2023 | 37237267 | PubTator, text mining | PubMed |
| Whole exome/genome sequencing in cyclic vomiting syndrome reveals multiple candidate genes, suggesting a model of elevated intracellular cations and mitochondrial dysfunction. | Front Neurol | 2023 | 37234784 | PubTator, text mining | PubMed |
| iPSC-derived reactive astrocytes from patients with multiple sclerosis protect cocultured neurons in inflammatory conditions. | J Clin Invest | 2023 | 37219933 | PubTator, text mining | PubMed |
| Combined inhibition of histone deacetylase and cytidine deaminase improves epigenetic potency of decitabine in colorectal adenocarcinomas. | Clin Epigenetics | 2023 | 37208732 | PubTator, text mining | PubMed |
| Mechanisms of N6‑methyladenosine modification in tumor development and potential therapeutic strategies (Review). | Int J Oncol | 2023 | 37203412 | PubTator, text mining | PubMed |
| In Silico Analysis of MicroRNA Expression Data in Liver Cancer. | Cancer Inform | 2023 | 37200943 | PubTator, text mining | PubMed |
| [Charcot-Marie-Tooth disease Patient Registry in Japan]. | Rinsho Shinkeigaku | 2023 | 37197973 | PubTator, text mining | PubMed |
| Intravenous Immunoglobulin Initiation in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims-based Cohort Study. | Neurol Ther | 2023 | 37195408 | PubTator, text mining | PubMed |
| Implications of CRNDE in prognosis, tumor immunity, and therapeutic sensitivity in low grade glioma patients. | Cancer Cell Int | 2023 | 37194105 | PubTator, text mining | PubMed |
| Diagnostic performance of deep learning-based reconstruction algorithm in 3D MR neurography. | Skeletal Radiol | 2023 | 37191931 | PubTator, text mining | PubMed |
| Improving Schwann Cell Differentiation from Human Adipose Stem Cells with Metabolic Glycoengineering. | Cells | 2023 | 37190099 | PubTator, text mining | PubMed |
| Neurological Adverse Effects of Immune Checkpoint Inhibitors and Chimeric Antigen Receptor T-Cell Therapy. | World J Oncol | 2023 | 37188042 | PubTator, text mining | PubMed |
| Stress granules: functions and mechanisms in cancer. | Cell Biosci | 2023 | 37179344 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5376/papers?page=16